- ASSOCIATE PROFESSOR | Radiology
- ASSOCIATE PROFESSOR | Surgery
- Interventional Radiology
- Chinese (Mandarin)
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai St. Luke's and Mount Sinai West
- Mount Sinai Queens
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
Edward Kim, MD, is Director of Interventional Oncology and Assistant Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at the Mount Sinai Medical Center. After completing medical school at the University of Medicine and Dentistry New Jersey-New Jersey Medical School in 2001, he did his residency at Nassau University Medical Center and completed his fellowship in Vascular and Interventional Radiology at The Mount Sinai School of Medicine. He subsequently joined the division of Vascular and Interventional Radiology.
Dr. Kim lectures around the country on various subjects in the field of Vascular and Interventional Radiology, including chemoembolization, Y90 radioembolization, radiofrequency ablation, GPS navigation guidance for percutaneous procedures, biliary interventions and the endovascular management of endoleaks.
Dr. Kim’s interests are with the growing subspecialty of interventional oncology and is the principal investigator on various trials involving drug eluting beads for chemoembolization, as well as radioembolization. He is also a pioneer in the use of image guided interventions, particularly with regards to GPS and fusion techniques to decrease radiation exposure to patients.
Dr. Kim has authored various scientific abstracts and manuscripts in the field of Vascular and Interventional Radiology. He has also been invited as faculty at various meetings including The Society of Interventional Radiology Annual Meeting, Global Embolization Symposium and Technologies, Advanced Interventional Management and New York Roentgen Society Annual Meeting.
Vascular & Interventional Radiology
- Electromagnetic Navigation Guidance and Fusion
- Interventional Oncology
- Peripherally Inserted Central Catheter
- Portal Hypertension TIPS-Transjujular Intrahepatic Portosystemic Shunt
- Radiofrequency Ablation
- Renal Artery Stenosis
Cancer, Imaging, Liver
MD, New Jersey Medical School
Morristown Memorial Hospital
Fellowship, Vascular Radiology
Mount Sinai Hospital
Chinese (Mandarin), English, Korean, Spanish
Phase 3 Prospective, Randomized, Blinded And Controlled Investigation Of Hepasphere/Quadrasphere Microspheres For Delivery Of Doxorubicin For The Treatment Of Hepatocellular Cancer
The purpose of this study is to compare and evaluate the effects of injection of chemotherapy (which is a standard treatment) with two different particles. Both QuadaSphere and particle PVA are cleared by the FDA f...
Biederman DM, Marinelli B, O'Connor PJ, Titano JJ, Patel RS, Kim E, Tabori NE, Nowakowski FS, Lookstein RA, Fischman AM. Transradial access for visceral endovascular interventions in morbidly obese patients: safety and feasibility. The journal of vascular access 2016 Mar;.
Posham R, Biederman DM, Patel RS, Kim E, Tabori NE, Nowakowski FS, Lookstein RA, Fischman AM. Transradial Approach for Noncoronary Interventions: A Single-Center Review of Safety and Feasibility in the First 1,500 Cases. Journal of vascular and interventional radiology : JVIR 2016 Feb; 27(2).
Blue RC, Lo GC, Kim E, Patel RS, Scott Nowakowski F, Lookstein RA, Fischman AM. Transjugular Intrahepatic Portosystemic Shunt Flow Reduction with Adjustable Polytetrafluoroethylene-Covered Balloon-Expandable Stents Using the . Cardiovascular and interventional radiology 2015 Dec;.
Biederman DM, Titano JJ, Lee KM, Pierobon ES, Schwartz M, Facciuto ME, Gunasekaran G, Florman S, Fischman AM, Patel RS, Tabori NE, Nowakowski FS, Kim E. Yttrium-90 Glass-Based Microsphere Radioembolization in the Treatment of Hepatocellular Carcinoma Secondary to the Hepatitis B Virus: Safety, Efficacy, and Survival. Journal of vascular and interventional radiology : JVIR 2015 Nov; 26(11).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Kim during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- BTG International Ltd.
Scientific Advisory Board:
- BTG International Ltd.
- Boston Scientific Corporation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.